SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14C - Other preliminary information statements:
SEC Accession No. 0001140361-19-023095
Filing Date
2019-12-23
Accepted
2019-12-23 16:06:46
Documents
1
Period of Report
2019-12-23

Document Format Files

Seq Description Document Type Size
1 PRE 14C nt10007004x1_pre14c.htm PRE 14C 831337
  Complete submission text file 0001140361-19-023095.txt   832391
Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44(0)207 400 3347
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: PRE 14C | Act: 34 | File No.: 001-37929 | Film No.: 191306049
SIC: 2834 Pharmaceutical Preparations